Title
Post-acute CoVid-19 syndrome (PACS) linked cardiovascularsymptoms
Authors
Allen Khakshooy*, 1 & Francesco Chiappelli2, 3
Affiliation
1Department of Internal Medicine, Valley Hospital Medical Center, Las Vegas, NV 89106, USA; 2Dental Group of Sherman Oaks, Sherman Oaks, CA 91403, USA; 3UCLA Center for the Health Sciences, Los Angeles, CA 90095, USA; *Corresponding author
Allen Khakshooy - E-mail: akhakshooy@gmail.com
Francesco Chiappelli - E-mail: Chiappelli.research@gmail.com
Article Type
Editorial
Date
Received May 1, 2024; Revised May 31, 2024; Accepted May 31, 2024, Published May 31, 2024
Abstract
Officials have marked the end of the CoVid-19 pandemic, yet we continue to learn more about the SARS-CoV2 virus itself and its lasting multidimensional effects after acute infection. Long COVID, or the post-acute CoViD-19 syndrome (PACS), manifests as a wide range of prolonged physical, mental, and emotional symptoms over at least 1 to 12 months after SARS-CoV2 infection. Here, we describe certain pervasive clinical consequences of PACS on the cardiovascular system, and insight on the potentially improved prognoses in heart failure patients.
Keywords
Post-acute CoViD-19 syndrome (PACS), long CoViD-19, cardiovascular disease, heart failure (HF), renin-angiotensin-aldosterone system (RAAS), left ventricular ejection fraction (LVEF), angiotensin II receptor-neprilysin inhibitors (ARNi)
Citation
Khakshooy & Chiappelli, Bioinformation 20(5): 412-414 (2024)
Edited by
Francesco Chiappelli
ISSN
0973-2063
Publisher
License
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
